Form 4: Chicago Pacific Founders Acquires Significant Warrant Position in P3 Health Partners

Chicago Pacific Founders has acquired warrants to purchase 71,406,480 shares of P3 Health Partners Class A Common Stock through a financing transaction.

Summary

• Chicago Pacific Founders UGP III, LLC, through its role as general partner of Chicago Pacific Founders GP III, L.P., has indirectly acquired warrants to purchase 71,406,480 shares of P3 Health Partners Class A Common Stock.
• The warrants were obtained as part of a financing transaction where P3 Health Group, LLC, a subsidiary of P3 Health Partners Inc., issued a promissory note and warrants to VBC Growth SPV 3, LLC.
• The financing agreement allows for up to $25 million in funding through several tranches.
• The warrants are exercisable immediately at a price of $0.2137 per share.
• The warrants will expire on December 12, 2031, or upon a change of control event of P3 Health Partners or its subsidiary.

Sentiment

Score: 7

Explanation: The document indicates a significant financing event, which is generally positive for the company's growth prospects. However, the potential dilution from the warrants and the debt obligations temper the overall sentiment.

Positives

• The financing transaction provides P3 Health Group, LLC with access to up to $25 million in funding.
• The immediate exercisability of the warrants provides flexibility to Chicago Pacific Founders.

Risks

• The warrants could dilute existing shareholders if exercised.
• The financing is tied to a promissory note, which could create debt obligations for P3 Health Group, LLC.

Future Outlook

The document does not contain specific forward-looking statements, but the financing transaction suggests P3 Health Group, LLC is seeking capital for future operations or expansion.

Industry Context

This transaction is typical of financing activities in the healthcare sector, where companies often use warrants and debt to raise capital. The involvement of a private equity firm like Chicago Pacific Founders is also common in this space.

Comparison to Industry Standards

• The use of warrants in conjunction with a promissory note is a common financing method for growth-stage healthcare companies.
• Similar transactions can be seen with companies like Oak Street Health and Cano Health, which have also utilized debt and equity instruments to fund expansion.
• The warrant exercise price of $0.2137 is relatively low, suggesting a potential upside for the warrant holder if the company performs well.

Stakeholder Impact

• Shareholders may experience dilution if the warrants are exercised.
• The financing provides P3 Health Group, LLC with capital to potentially grow its business, which could benefit employees and customers.

Key Dates

Keywords

warrants, financing, P3 Health Partners, Chicago Pacific Founders, Class A Common Stock, promissory note, VBC Growth SPV 3, equity